<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://supergrowthmedia.com/press-releases/invivyd-reports-third-quarter-2026-financial-results-and-recent-business-highlights</loc><news:news><news:publication><news:name>Super Growth Media</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T12:34:18.465Z</news:publication_date><news:title>Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights</news:title></news:news></url>
<url><loc>https://supergrowthmedia.com/press-releases/inspiremd-announces-pricing-of-dollar375-million-public-offering</loc><news:news><news:publication><news:name>Super Growth Media</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T12:28:15.813Z</news:publication_date><news:title>InspireMD Announces Pricing of $37.5 Million Public Offering</news:title></news:news></url>
<url><loc>https://supergrowthmedia.com/press-releases/xtant-medical-reports-third-quarter-2026-financial-results</loc><news:news><news:publication><news:name>Super Growth Media</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T12:26:59.308Z</news:publication_date><news:title>Xtant Medical Reports Third Quarter 2026 Financial Results</news:title></news:news></url>
<url><loc>https://supergrowthmedia.com/press-releases/professor-eicke-latz-has-co-founded-five-biotechnology-companies-including-ifm</loc><news:news><news:publication><news:name>Super Growth Media</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T12:24:51.846Z</news:publication_date><news:title>Professor Eicke Latz has co-founded five biotechnology companies, including IFM Therapeutics, Odyssey Therapeutics, Metaimmune Therapeutics, DiosCure Therapeutics, and Beren Therapeutics. His entrepreneurial efforts have focused on translating cutting-edge discoveries in innate immunity and inflammation into novel therapeutic approaches, with programs advancing into clinical development and leading to successful exits and initial public offerings. Through his biopharma ventures, Dr. Latz is bridging fundamental disease biology insights to therapeutic innovation, unmet medical needs and value creation.</news:title></news:news></url>
<url><loc>https://supergrowthmedia.com/press-releases/screenpoint-medical-appoints-parul-sharma-as-chief-commercial-officer</loc><news:news><news:publication><news:name>Super Growth Media</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T09:05:21.213Z</news:publication_date><news:title>ScreenPoint Medical Appoints Parul Sharma as Chief Commercial Officer</news:title></news:news></url>
<url><loc>https://supergrowthmedia.com/roundups/marketing-week-of-nov-9-2026</loc><news:news><news:publication><news:name>Super Growth Media</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T10:36:00.000Z</news:publication_date><news:title>BlueMedia, NinjaCat launch AI offerings: the week in marketing releases</news:title></news:news></url>
<url><loc>https://supergrowthmedia.com/roundups/business-week-of-nov-9-2026</loc><news:news><news:publication><news:name>Super Growth Media</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T10:25:00.000Z</news:publication_date><news:title>YETI, Edgewell, Select Water Solutions post results: the week in business</news:title></news:news></url>
<url><loc>https://supergrowthmedia.com/roundups/finance-and-banking-week-of-nov-9-2026</loc><news:news><news:publication><news:name>Super Growth Media</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T10:14:00.000Z</news:publication_date><news:title>Aflac, Cincinnati Financial declare dividends: the week in finance</news:title></news:news></url>
</urlset>